Russell Investments Group’s Apollo Endosurgery, Inc. APEN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | – | Sell |
-103,124
| Closed | -$1.02M | – | 3586 |
|
|
2023
Q1 | $1.02M | Sell |
103,124
-490,681
| -83% | -$4.86M | ﹤0.01% | 1950 |
|
|
2022
Q4 | $5.92M | Sell |
593,805
-358,927
| -38% | -$2.68M | 0.01% | 1010 |
|
|
2022
Q3 | $5.25M | Buy |
+952,732
| New | +$5.28M | 0.01% | 1024 |
|
|
2022
Q2 | – | Sell |
-92,760
| Closed | -$559K | – | 2996 |
|
|
2022
Q1 | $559K | Sell |
92,760
-31,981
| -26% | -$195K | ﹤0.01% | 2183 |
|
|
2021
Q4 | $1.05M | Buy |
+124,741
| New | +$1.09M | ﹤0.01% | 2122 |
|
|
2020
Q1 | – | Sell |
-74,401
| Closed | -$212K | – | 3182 |
|
|
2019
Q4 | $212K | Sell |
74,401
-187,493
| -72% | -$543K | ﹤0.01% | 2694 |
|
|
2019
Q3 | $871K | Sell |
261,894
-78,590
| -23% | -$249K | ﹤0.01% | 2067 |
|
|
2019
Q2 | $1.11M | Sell |
340,484
-12,646
| -4% | -$45K | ﹤0.01% | 1941 |
|
|
2019
Q1 | $1.32M | Sell |
353,130
-11,904
| -3% | -$41.6K | ﹤0.01% | 1921 |
|
|
2018
Q4 | $1.26M | Sell |
365,034
-45,200
| -11% | -$223K | ﹤0.01% | 1824 |
|
|
2018
Q3 | $2.94M | Sell |
410,234
-5,168
| -1% | -$40.1K | 0.01% | 1556 |
|
|
2018
Q2 | $2.9M | Buy |
415,402
+84,239
| +25% | +$524K | 0.01% | 1562 |
|
|
2018
Q1 | $2.04M | Buy |
331,163
+23,128
| +8% | +$146K | ﹤0.01% | 1824 |
|
|
2017
Q4 | $1.73M | Buy |
308,035
+32,864
| +12% | +$150K | ﹤0.01% | 1893 |
|
|
2017
Q3 | $1.29M | Buy |
+275,171
| New | +$1.45M | ﹤0.01% | 2007 |
|
Russell Investments Group's APEN Position: Q2 2023 in Review
Russell Investments Group sold out of Apollo Endosurgery, Inc. (APEN) in Q2 2023, closing a stake of 103,124 shares — an estimated $1.02M sold.
Russell Investments Group first reported a position in APEN in Q3 2017 and held it in 15 quarters. The position peaked at $5.92M in Q4 2022. 0 funds tracked by Wall St. Rank hold APEN as of Q2 2023.
- Russell Investments Group reported no remaining Apollo Endosurgery, Inc. position as of Q2 2023 after selling out during the quarter.
- Russell Investments Group sold 103,124 Apollo Endosurgery, Inc. shares in Q2 2023, an estimated $1.02M.
- Russell Investments Group first reported a position in Apollo Endosurgery, Inc. in Q3 2017 and held it in 15 quarters.
- Russell Investments Group's Apollo Endosurgery, Inc. position peaked at $5.92M in Q4 2022.
- 0 funds tracked by Wall St. Rank held Apollo Endosurgery, Inc. as of Q2 2023.
Based on Russell Investments Group's 13F filing for Q2 2023, filed 10 Aug 2023.